Elaine T. Alarid

University of Wisconsin–Madison — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

32h-index4.1kcitations92works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Estrogen and related hormone effects(40), Cytokine Signaling Pathways and Interactions(18), Cancer Cells and Metastasis(17), Ubiquitin and proteasome pathways(11), Genomics and Chromatin Dynamics(9)

Publications92 total

7961 EMT Plasticity Induced by GRHL2 Overexpression Stimulates Dormancy and Enriches Stem Cell Characteristics in ER+ Breast Cancer Cells
Journal of the Endocrine Society·2024Open Access
7615 Genomic Consequences of GRHL2 Overexpression in ER+ Breast Cancer Cells
Journal of the Endocrine Society·2024Open Access
7961 EMT Plasticity Induced By GRHL2 Overexpression Stimulates Dormancy And Enriches Stem Cell Characteristics In ER+ Breast Cancer Cells
Journal of the Endocrine Society·2024Open Access
Elevated GRHL2 Imparts Plasticity in ER-Positive Breast Cancer Cells
Cancers·2024· 1 citedOpen Access
THU491 GRHL2 Overexpression In Breast Cancer Progression
Journal of the Endocrine Society·2023Open Access
Supplemental Table 2 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Supplemental Table 3 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Supplemental Table 1 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Supplemental Materials and Methods and Figure Legends from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Supplemental Materials and Methods and Figure Legends from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Supplemental Table 3 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Supplemental Table 1 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Supplementary Figures 1-6 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Data from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Data from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Supplemental Table 2 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Supplementary Figures 1-6 from The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers
2023Open Access
Progesterone Receptor–Mediated Regulation of Cellular Glucose and 18F-Fluorodeoxyglucose Uptake in Breast Cancer
Journal of the Endocrine Society·2022· 4 citedOpen Access
GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression
Molecular and Cellular Biology·2022· 15 citedOpen Access
GRHL2 enhances phosphorylated estrogen receptor DNA-binding and regulates ER-mediated transcriptional activation and repression
2022Open Access
page 1 of 5Next →

Frequent Co-authors

Natalia Solodin(16), David J. Beebe(11), Stephanie J. Ellison-Zelski(6), Scott M. Berry(5), Amy M. Fowler(5), Prashant Rajbhandari(5), Linda A. Schuler(4), Pamela L. Mellon(4), Gerald R. Cunha(4), Molly Morgan(4), Brian P. Johnson(4), Rebecca Reese(4), Ginny L. Powers(4), Kyle T. Helzer(4), Christopher C. Valley(3), Mara T. Preisler‐Mashek(3), Keil J. Regehr(2), Maribella Domenech(2), Annemarie A. Donjacour(2), Eugenie L. Boutin(2)